Any 0 3 0 3 O
female 4 10 4 10 B-gender
participant 11 22 11 22 I-gender
of 23 25 23 25 O
childbearing 26 38 26 38 O
potential 39 48 39 48 O
( 49 50 49 50 O
see 50 53 50 53 O
Appendix 54 62 54 62 O
1 63 64 63 64 O
for 65 68 65 68 O
definition 69 79 69 79 O
) 79 80 79 80 O
and 81 84 81 84 O
any 85 88 85 88 O
male 89 93 89 93 O
participant 94 105 94 105 O
able 106 110 106 110 O
to 111 113 111 113 O
father 114 120 114 120 O
children 121 129 121 129 O
must 130 134 130 134 O
have 135 139 135 139 O
( 140 141 140 141 O
or 141 143 141 143 O
have 144 148 144 148 O
a 149 150 149 150 O
partner 151 158 151 158 O
who 159 162 159 162 O
has 163 166 163 166 O
) 166 167 166 167 O
had 168 171 168 171 O
a 172 173 172 173 O
hysterectomy 174 186 174 186 B-contraception_consent
or 187 189 187 189 O
vasectomy 190 199 190 199 B-contraception_consent
, 199 200 199 200 O
be 201 203 201 203 O
completely 204 214 204 214 O
abstinent 215 224 215 224 O
* 224 225 224 225 O
from 226 230 226 230 O
intercourse 231 242 231 242 O
or 243 245 243 245 O
must 246 250 246 250 O
agree 251 256 251 256 B-contraception_consent
to 257 259 257 259 I-contraception_consent
practice 260 268 260 268 I-contraception_consent
two 269 272 269 272 I-contraception_consent
acceptable 273 283 273 283 I-contraception_consent
methods 284 291 284 291 I-contraception_consent
of 292 294 292 294 I-contraception_consent
contraception 295 308 295 308 I-contraception_consent
throughout 309 319 309 319 O
the 320 323 320 323 O
course 324 330 324 330 O
of 331 333 331 333 O
the 334 337 334 337 O
study 338 343 338 343 O
and 344 347 344 347 O
for 348 351 348 351 O
at 352 354 352 354 O
least 355 360 355 360 O
one 361 364 361 364 B-lower_bound
week 365 369 365 369 I-lower_bound
after 370 375 370 375 I-lower_bound
investigational 376 391 376 391 B-treatment
product 392 399 392 399 I-treatment
( 400 401 400 401 I-treatment
IP 401 403 401 403 I-treatment
) 403 404 403 404 I-treatment
discontinuation 405 420 405 420 O

Any 0 3 421 424 O
female 4 10 425 431 B-gender
participant 11 22 432 443 I-gender
of 23 25 444 446 O
childbearing 26 38 447 459 O
potential 39 48 460 469 O
( 49 50 470 471 O
see 50 53 471 474 O
Appendix 54 62 475 483 O
1 63 64 484 485 O
for 65 68 486 489 O
definition 69 79 490 500 O
) 79 80 500 501 O
must 81 85 502 506 O
have 86 90 507 511 O
a 91 92 512 513 O
negative 93 101 514 522 B-pregnancy
pregnancy 102 111 523 532 I-pregnancy
test 112 116 533 537 O
at 117 119 538 540 O
screening 120 129 541 550 O
and 130 133 551 554 O
be 134 136 555 557 O
willing 137 144 558 565 O
to 145 147 566 568 O
undergo 148 155 569 576 O
pregnancy 156 165 577 586 O
tests 166 171 587 592 O
throughout 172 182 593 603 O
the 183 186 604 607 O
study 187 192 608 613 O

Any 0 3 614 617 O
female 4 10 618 624 B-gender
participant 11 22 625 636 I-gender
of 23 25 637 639 O
childbearing 26 38 640 652 O
potential 39 48 653 662 O
( 49 50 663 664 O
see 50 53 664 667 O
Appendix 54 62 668 676 O
1 63 64 677 678 O
for 65 68 679 682 O
definition 69 79 683 693 O
) 79 80 693 694 O
that 81 85 695 699 O
is 86 88 700 702 O
pregnant 89 97 703 711 B-pregnancy
, 97 98 711 712 O
breast 99 105 713 719 O
- 105 106 719 720 O
feeding 106 113 720 727 O
or 114 116 728 730 O
planning 117 125 731 739 B-pregnancy
to 126 128 740 742 I-pregnancy
become 129 135 743 749 I-pregnancy
pregnant 136 144 750 758 I-pregnancy
during 145 151 759 765 O
the 152 155 766 769 O
study 156 161 770 775 O

Branch 0 6 776 782 O
or 7 9 783 785 O
central 10 17 786 793 B-chronic_disease
retinal 18 25 794 801 I-chronic_disease
vein 26 30 802 806 I-chronic_disease
or 31 33 807 809 O
artery 34 40 810 816 B-chronic_disease
occlusion 41 50 817 826 I-chronic_disease

Current 0 7 827 834 O
evidence 8 16 835 843 O
of 17 19 844 846 O
choroidal 20 29 847 856 B-chronic_disease
neovascularization 30 48 857 875 I-chronic_disease
( 49 50 876 877 I-chronic_disease
CNV 50 53 877 880 I-chronic_disease
) 53 54 880 881 I-chronic_disease
as 55 57 882 884 O
determined 58 68 885 895 O
by 69 71 896 898 O
the 72 75 899 902 O
treating 76 84 903 911 O
physician 85 94 912 921 O
or 95 97 922 924 O
a 98 99 925 926 O
history 100 107 927 934 O
of 108 110 935 937 O
treatments 111 121 938 948 B-treatment
for 122 125 949 952 O
CNV 126 129 953 956 O

Evidence 0 8 957 965 O
of 9 11 966 968 O
retinal 12 19 969 976 B-chronic_disease
atrophy 20 27 977 984 I-chronic_disease
due 28 31 985 988 O
to 32 34 989 991 O
causes 35 41 992 998 O
other 42 47 999 1004 O
than 48 52 1005 1009 O
atrophic 53 61 1010 1018 B-chronic_disease
AMD 62 65 1019 1022 I-chronic_disease

GA 0 2 1023 1025 B-chronic_disease
is 3 5 1026 1028 O
defined 6 13 1029 1036 O
as 14 16 1037 1039 O
one 17 20 1040 1043 O
or 21 23 1044 1046 O
more 24 28 1047 1051 O
well 29 33 1052 1056 O
- 33 34 1056 1057 O
defined 34 41 1057 1064 O
and 42 45 1065 1068 O
often 46 51 1069 1074 O
circular 52 60 1075 1083 O
patches 61 68 1084 1091 O
of 69 71 1092 1094 O
partial 72 79 1095 1102 O
or 80 82 1103 1105 O
complete 83 91 1106 1114 O
depigmentation 92 106 1115 1129 O
of 107 109 1130 1132 O
the 110 113 1133 1136 O
RPE 114 117 1137 1140 B-clinical_variable
, 117 118 1140 1141 O
typically 119 128 1142 1151 O
with 129 133 1152 1156 O
exposure 134 142 1157 1165 O
of 143 145 1166 1168 O
underlying 146 156 1169 1179 O
choroidal 157 166 1180 1189 O
blood 167 172 1190 1195 O
vessels 173 180 1196 1203 O
. 180 181 1203 1204 O
Even 182 186 1205 1209 O
if 187 189 1210 1212 O
much 190 194 1213 1217 O
of 195 197 1218 1220 O
the 198 201 1221 1224 O
RPE 202 205 1225 1228 O
appears 206 213 1229 1236 O
to 214 216 1237 1239 O
be 217 219 1240 1242 O
preserved 220 229 1243 1252 O
and 230 233 1253 1256 O
large 234 239 1257 1262 O
choroidal 240 249 1263 1272 O
vessels 250 257 1273 1280 O
are 258 261 1281 1284 O
not 262 265 1285 1288 O
visible 266 273 1289 1296 O
, 273 274 1296 1297 O
a 275 276 1298 1299 O
round 277 282 1300 1305 O
patch 283 288 1306 1311 O
of 289 291 1312 1314 O
RPE 292 295 1315 1318 O
partial 296 303 1319 1326 O
depigmentation 304 318 1327 1341 O
may 319 322 1342 1345 O
be 323 325 1346 1348 O
classified 326 336 1349 1359 O
as 337 339 1360 1362 O
early 340 345 1363 1368 O
GA 346 348 1369 1371 O
. 348 349 1371 1372 O
The 350 353 1373 1376 O
GA 354 356 1377 1379 O
in 357 359 1380 1382 O
the 360 363 1383 1386 O
study 364 369 1387 1392 O
eye 370 373 1393 1396 O
must 374 378 1397 1401 O
be 379 381 1402 1404 O
able 382 386 1405 1409 O
to 387 389 1410 1412 O
be 390 392 1413 1415 O
photographed 393 405 1416 1428 O
in 406 408 1429 1431 O
their 409 414 1432 1437 O
entirety 415 423 1438 1446 O
, 423 424 1446 1447 O
and 425 428 1448 1451 O
it 429 431 1452 1454 O
must 432 436 1455 1459 O
not 437 440 1460 1463 O
be 441 443 1464 1466 O
contiguous 444 454 1467 1477 O
with 455 459 1478 1482 O
any 460 463 1483 1486 O
areas 464 469 1487 1492 O
of 470 472 1493 1495 O
peripapillary 473 486 1496 1509 B-chronic_disease
atrophy 487 494 1510 1517 I-chronic_disease
, 494 495 1517 1518 O
which 496 501 1519 1524 O
can 502 505 1525 1528 O
complicate 506 516 1529 1539 O
area 517 521 1540 1544 O
measurements 522 534 1545 1557 O

History 0 7 1558 1565 O
of 8 10 1566 1568 O
vitreoretinal 11 24 1569 1582 B-treatment
surgery 25 32 1583 1590 I-treatment

Macular 0 7 1591 1598 B-chronic_disease
hole 8 12 1599 1603 I-chronic_disease

Need 0 4 1604 1608 O
for 5 8 1609 1612 O
ocular 9 15 1613 1619 B-treatment
surgery 16 23 1620 1627 I-treatment
during 24 30 1628 1634 O
the 31 34 1635 1638 O
course 35 41 1639 1645 O
of 42 44 1646 1648 O
the 45 48 1649 1652 O
study 49 54 1653 1658 O

Participant 0 11 1659 1670 O
has 12 15 1671 1674 O
a 16 17 1675 1676 O
history 18 25 1677 1684 O
of 26 28 1685 1687 O
chronic 29 36 1688 1695 B-chronic_disease
hepatitis 37 46 1696 1705 I-chronic_disease
or 47 49 1706 1708 O
liver 50 55 1709 1714 B-chronic_disease
failure 56 63 1715 1722 I-chronic_disease

Participant 0 11 1723 1734 O
has 12 15 1735 1738 O
a 16 17 1739 1740 O
history 18 25 1741 1748 O
of 26 28 1749 1751 O
chronic 29 36 1752 1759 B-chronic_disease
renal 37 42 1760 1765 I-chronic_disease
failure 43 50 1766 1773 I-chronic_disease
requiring 51 60 1774 1783 O
dialysis 61 69 1784 1792 B-treatment
or 70 72 1793 1795 O
kidney 73 79 1796 1802 B-treatment
transplant 80 90 1803 1813 I-treatment

Participant 0 11 1814 1825 O
has 12 15 1826 1829 O
a 16 17 1830 1831 O
history 18 25 1832 1839 O
of 26 28 1840 1842 O
thyroid 29 36 1843 1850 B-cancer
cancer 37 43 1851 1857 I-cancer

Participant 0 11 1858 1869 O
has 12 15 1870 1873 O
a 16 17 1874 1875 O
prior 18 23 1876 1881 O
history 24 31 1882 1889 O
of 32 34 1890 1892 O
idiopathic 35 45 1893 1903 B-chronic_disease
intracranial 46 58 1904 1916 I-chronic_disease
hypertension 59 71 1917 1929 I-chronic_disease

Participant 0 11 1930 1941 O
has 12 15 1942 1945 O
an 16 18 1946 1948 O
allergy 19 26 1949 1956 O
or 27 29 1957 1959 O
hypersensitivity 30 46 1960 1976 O
to 47 49 1977 1979 O
minocycline 50 61 1980 1991 B-allergy_name
or 62 64 1992 1994 O
any 65 68 1995 1998 O
drug 69 73 1999 2003 O
in 74 76 2004 2006 O
the 77 80 2007 2010 O
tetracycline 81 93 2011 2023 B-allergy_name
family 94 100 2024 2030 I-allergy_name

Participant 0 11 2031 2042 O
is 12 14 2043 2045 O
actively 15 23 2046 2054 O
receiving 24 33 2055 2064 O
study 34 39 2065 2070 O
therapy 40 47 2071 2078 B-treatment
in 48 50 2079 2081 O
another 51 58 2082 2089 O
investigational 59 74 2090 2105 O
study 75 80 2106 2111 O

Participant 0 11 2112 2123 O
is 12 14 2124 2126 O
currently 15 24 2127 2136 O
taking 25 31 2137 2143 O
minocycline 32 43 2144 2155 B-treatment
or 44 46 2156 2158 O
another 47 54 2159 2166 O
tetracycline 55 67 2167 2179 B-treatment
medication 68 78 2180 2190 I-treatment

Participant 0 11 2191 2202 O
is 12 14 2203 2205 O
on 15 17 2206 2208 O
ocular 18 24 2209 2215 B-treatment
or 25 27 2216 2218 O
systemic 28 36 2219 2227 B-treatment
medications 37 48 2228 2239 I-treatment
known 49 54 2240 2245 O
to 55 57 2246 2248 O
be 58 60 2249 2251 O
toxic 61 66 2252 2257 O
to 67 69 2258 2260 O
the 70 73 2261 2264 O
lens 74 78 2265 2269 O
, 78 79 2269 2270 O
retina 80 86 2271 2277 O
or 87 89 2278 2280 O
optic 90 95 2281 2286 O
nerve 96 101 2287 2292 O
( 102 103 2293 2294 O
e.g. 103 107 2294 2298 O
, 107 108 2298 2299 O
ethambutol 109 119 2300 2310 B-treatment
, 119 120 2310 2311 O
chloroquine 121 132 2312 2323 B-treatment
, 132 133 2323 2324 O
or 134 136 2325 2327 O
hydroxychloroquine 137 155 2328 2346 B-treatment
) 155 156 2346 2347 O

Participant 0 11 2348 2359 O
is 12 14 2360 2362 O
taking 15 21 2363 2369 O
any 22 25 2370 2373 O
medication 26 36 2374 2384 B-treatment
that 37 41 2385 2389 O
could 42 47 2390 2395 O
adversely 48 57 2396 2405 O
interact 58 66 2406 2414 O
with 67 71 2415 2419 O
minocycline 72 83 2420 2431 B-treatment
such 84 88 2432 2436 O
as 89 91 2437 2439 O
methoxyflurane 92 106 2440 2454 B-treatment

Participant 0 11 2455 2466 O
must 12 16 2467 2471 O
be 17 19 2472 2474 O
55 20 22 2475 2477 B-lower_bound
years 23 28 2478 2483 I-lower_bound
of 29 31 2484 2486 O
age 32 35 2487 2490 B-age
or 36 38 2491 2493 O
older 39 44 2494 2499 O

Participant 0 11 2500 2511 O
must 12 16 2512 2516 O
have 17 21 2517 2521 O
evidence 22 30 2522 2530 O
of 31 33 2531 2533 O
early 34 39 2534 2539 O
or 40 42 2540 2542 O
intermediate 43 55 2543 2555 O
AMD 56 59 2556 2559 B-chronic_disease
as 60 62 2560 2562 O
defined 63 70 2563 2570 O
by 71 73 2571 2573 O
characteristic 74 88 2574 2588 O
presence 89 97 2589 2597 O
of 98 100 2598 2600 O
drusen 101 107 2601 2607 O
and/or 108 114 2608 2614 O
pigmentary 115 125 2615 2625 O
changes 126 133 2626 2633 O

Participant 0 11 2634 2645 O
must 12 16 2646 2650 O
have 17 21 2651 2655 O
normal 22 28 2656 2662 O
renal 29 34 2663 2668 O
function 35 43 2669 2677 O
and 44 47 2678 2681 O
liver 48 53 2682 2687 O
function 54 62 2688 2696 O
or 63 65 2697 2699 O
have 66 70 2700 2704 O
mild 71 75 2705 2709 O
abnormalities 76 89 2710 2723 O
not 90 93 2724 2727 O
above 94 99 2728 2733 O
grade 100 105 2734 2739 B-upper_bound
1 106 107 2740 2741 I-upper_bound
as 108 110 2742 2744 O
defined 111 118 2745 2752 O
by 119 121 2753 2755 O
the 122 125 2756 2759 O
Common 126 132 2760 2766 O
Terminology 133 144 2767 2778 O
Criteria 145 153 2779 2787 O
for 154 157 2788 2791 O
Adverse 158 165 2792 2799 O
Events 166 172 2800 2806 O
v4.0 173 177 2807 2811 O
( 178 179 2812 2813 O
CTCAE 179 184 2813 2818 O
) 184 185 2818 2819 O

Pathologic 0 10 2820 2830 B-chronic_disease
myopia 11 17 2831 2837 I-chronic_disease

Pseudovitelliform 0 17 2838 2855 O
maculopathy 18 29 2856 2867 I-chronic_disease

Recent 0 6 2868 2874 O
history 7 14 2875 2882 O
of 15 17 2883 2885 O
lens 18 22 2886 2890 B-clinical_variable
removal 23 30 2891 2898 I-clinical_variable
( 31 32 2899 2900 O
less 32 36 2900 2904 O
than 37 41 2905 2909 O
3 42 43 2910 2911 B-upper_bound
months 44 50 2912 2918 I-upper_bound
) 50 51 2918 2919 O
or 52 54 2920 2922 O
Yttrium 55 62 2923 2930 B-treatment
Aluminum 63 71 2931 2939 I-treatment
Garnet 72 78 2940 2946 I-treatment
( 79 80 2947 2948 I-treatment
YAG 80 83 2948 2951 I-treatment
) 83 84 2951 2952 I-treatment
laser 85 90 2953 2958 I-treatment
capsulotomy 91 102 2959 2970 I-treatment
( 103 104 2971 2972 O
less 104 108 2972 2976 O
than 109 113 2977 2981 O
1 114 115 2982 2983 B-upper_bound
month 116 121 2984 2989 I-upper_bound
) 121 122 2989 2990 O

The 0 3 2991 2994 O
VA 4 6 2995 2997 B-clinical_variable
of 7 9 2998 3000 O
the 10 13 3001 3004 O
study 14 19 3005 3010 O
eye 20 23 3011 3014 O
should 24 30 3015 3021 O
be 31 33 3022 3024 O
greater 34 41 3025 3032 O
than 42 46 3033 3037 O
or 47 49 3038 3040 O
equal 50 55 3041 3046 O
to19 56 60 3047 3051 O
E 61 62 3052 3053 O
- 62 63 3053 3054 O
ETDRS 63 68 3054 3059 O
letters 69 76 3060 3067 O
( 77 78 3068 3069 O
i.e. 78 82 3069 3073 O
, 82 83 3073 3074 O
20/400 84 90 3075 3081 B-lower_bound
or 91 93 3082 3084 O
better 94 100 3085 3091 O
) 100 101 3091 3092 O

The 0 3 3093 3096 O
study 4 9 3097 3102 O
eye 10 13 3103 3106 O
must 14 18 3107 3111 O
have 19 23 3112 3116 O
at 24 26 3117 3119 O
least 27 32 3120 3125 O
( 33 34 3126 3127 O
Omega 34 39 3127 3132 O
) 39 40 3132 3133 O
disc 41 45 3134 3138 O
area 46 50 3139 3143 O
( 51 52 3144 3145 O
approximately 52 65 3145 3158 O
1 66 67 3159 3160 B-lower_bound
mm(2 68 72 3161 3165 I-lower_bound
) 72 73 3165 3166 I-lower_bound
) 73 74 3166 3167 O
of 75 77 3168 3170 O
GA 78 80 3171 3173 O
compatible 81 91 3174 3184 O
with 92 96 3185 3189 O
dry 97 100 3190 3193 B-chronic_disease
AMD 101 104 3194 3197 I-chronic_disease

The 0 3 3198 3201 O
total 4 9 3202 3207 B-clinical_variable
area 10 14 3208 3212 I-clinical_variable
of 15 17 3213 3215 I-clinical_variable
GA 18 20 3216 3218 I-clinical_variable
lesions 21 28 3219 3226 I-clinical_variable
combined 29 37 3227 3235 O
should 38 44 3236 3242 O
be 45 47 3243 3245 O
less 48 52 3246 3250 O
than 53 57 3251 3255 O
7.0 58 61 3256 3259 B-upper_bound
MPS 62 65 3260 3263 I-upper_bound
disc 66 70 3264 3268 I-upper_bound
areas 71 76 3269 3274 I-upper_bound
( 77 78 3275 3276 I-upper_bound
DA 78 80 3276 3278 I-upper_bound
) 80 81 3278 3279 I-upper_bound
( 82 83 3280 3281 I-upper_bound
17.78 83 88 3281 3286 I-upper_bound
mm(2 89 93 3287 3291 I-upper_bound
) 93 94 3291 3292 I-upper_bound
) 94 95 3292 3293 I-upper_bound
as 96 98 3294 3296 O
evident 99 106 3297 3304 O
on 107 109 3305 3307 O
FAF 110 113 3308 3311 B-treatment
imaging 114 121 3312 3319 I-treatment

Uveitis 0 7 3320 3327 B-chronic_disease

hormonal 0 8 3328 3336 B-contraception_consent
contraception 9 22 3337 3350 I-contraception_consent
( 23 24 3351 3352 O
i.e. 24 28 3352 3356 O
, 28 29 3356 3357 O
birth 30 35 3358 3363 B-contraception_consent
control 36 43 3364 3371 I-contraception_consent
pills 44 49 3372 3377 I-contraception_consent
, 49 50 3377 3378 O
injected 51 59 3379 3387 B-contraception_consent
hormones 60 68 3388 3396 I-contraception_consent
, 68 69 3396 3397 O
dermal 70 76 3398 3404 B-contraception_consent
patch 77 82 3405 3410 I-contraception_consent
or 83 85 3411 3413 O
vaginal 86 93 3414 3421 B-contraception_consent
ring 94 98 3422 3426 I-contraception_consent
) 98 99 3426 3427 O

intrauterine 0 12 3428 3440 B-contraception_consent
device 13 19 3441 3447 I-contraception_consent

non 0 3 3448 3451 B-chronic_disease
- 3 4 3451 3452 I-chronic_disease
proliferative 4 17 3452 3465 I-chronic_disease
diabetic 18 26 3466 3474 I-chronic_disease
retinopathy 27 38 3475 3486 I-chronic_disease
involving 39 48 3487 3496 O
10 49 51 3497 3499 B-lower_bound
or 52 54 3500 3502 O
more 55 59 3503 3507 O
hemorrhages 60 71 3508 3519 B-chronic_disease
or 72 74 3520 3522 O
microaneurysms 75 89 3523 3537 B-chronic_disease
, 89 90 3537 3538 O
or 91 93 3539 3541 O
active 94 100 3542 3548 O
proliferative 101 114 3549 3562 O
diabetic 115 123 3563 3571 O
retinopathy 124 135 3572 3583 O

surgical 0 8 3584 3592 B-treatment
sterilization 9 22 3593 3606 I-treatment
( 23 24 3607 3608 O
hysterectomy 24 36 3608 3620 B-treatment
or 37 39 3621 3623 O
tubal 40 45 3624 3629 B-treatment
ligation 46 54 3630 3638 I-treatment
) 54 55 3638 3639 O

